CIDRAP newsletters options
Researchers find no difference in health worker infections from flu, other viruses.
Health officials in the Democratic Republic of the Congo (DRC) confirmed 6 more Ebola infections, raising the overall outbreak total to 3,049, according to the World Health Organization (WHO) online dashboard today. Also, outbreak responders are still investigating 327 suspected cases.
Ten more people died from their infections, raising the fatality count to 2,045.
A girl diagnosed in Uganda may have acquired her infection in a healthcare facility, the WHO says.
Officials confirm 19 new cases and declare the outbreak in Brooklyn over after almost a year.
CARB-X today announced an award of more than $1.6 million to biopharmaceutical company SutroVax of Foster City, Calif., to develop a vaccine to prevent infections caused by Group A Streptococcus.
Genentech, part of the Roche Group, yesterday announced promising phase 3 trial findings for the use of one-dose baloxavir marboxil (Xofluza) to safely treat flu in children, according to results presented on Sep 1 during the Options X Congress in Singapore.
Cases have now reached 3,017, and a new hot spot in Ituri province has developed.
In the latest global polio developments, Pakistan reported five more wild poliovirus type 1 (WPV1) cases, while two African nations—Nigeria and the Democratic Republic of the Congo (DRC)—reported more positive circulating vaccine-derived polio type 2 (cVDPV2) detections. The details appear today in the weekly update from the Global Polio Eradication Initiative (GPEI).
The US Food and Drug Administration (FDA) says it will now recommend that hospitals move away from using duodenoscopes with reusable parts because of concerns about patient infections that have been linked to cleaning issues.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A letter argues that the EPA has ignored other federal agencies and scientific evidence.
The girl's Ebola symptoms were flagged at an entry point in the same district of Uganda where imported cases were detected in June.
As risk areas expand, the CWD regulation updates will apply to more Minnesota hunters this season.
As measles cases this year pile up in Europe, four European nations—Albania, the Czech Republic, Greece, and the United Kingdom—have lost their measles elimination status, the World Health Organization (WHO) Regional Office for Europe said today.
In another new development, two experts say more research on Ebola in breastmilk is urgently needed to guide recommendations.
A survey of Israeli physicians and analysis of patient data has found that antibiotics are overused in patients with end-of-life advanced directives, Israeli researchers reported today in Infection Control and Hospital Epidemiology.
Six more Ebola cases were confirmed in the Democratic Republic of the Congo (DRC) Ebola outbreak, raising the overall total to 2,983, according to numbers reflected today on the World Health Organization (WHO) online Ebola dashboard.
Health officials are still investigating 397 suspected infections. Four more people died from their infections, bringing the fatality count to 1,990.
The United Nations Development Programme (UNDP) yesterday announced a joint initiative with environmental and industry groups to reduce the amount of antibiotic discharge from pharmaceutical manufacturing facilities.
After establishing its Chronic Wasting Disease (CWD) Program in March, today the University of Minnesota's Center for Infectious Disease Research and Policy (CIDRAP) launched a new online CWD Resource Center for educating the public, hunters, medical and public health professionals, wildlife scientists, veterinarians, and policymakers about the disease.
A study conducted in Dutch hospitals has found that an isolation strategy of contact precautions in a multiple-bed hospital room was non-inferior to a strategy of contact precautions in a single-bed room for preventing the spread of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, Dutch researchers reported in The Lancet Infectious Diseases.
